Search research articles
Contact Us
Filters
Showing results (91-100 of 108) with videos related to
Page
of 11
Sort By:
Scientific Reports
|
March 21, 2026
Construct validity of real-world digital mobility outcomes in patients after proximal femoral fracture: a cross-sectional observational study
Tobias Eckert, Martin Aursand Berge, Michael Long, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 17, 2019
Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks
Roman C Maron, Michael Weichenthal, Jochen S Utikal, et al.
Trials
|
January 17, 2026
Recruitment of the multiple sclerosis cohort within the European Mobilise-D clinical validation study-lessons learnt, baseline demographics and clinical characteristics
Gavin Brittain, Ellen Buckley, Vita Lanfranchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 17, 2024
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomas
Philipp Jansen, Wolfgang Galetzka, Georg C Lodde, et al.
The International Journal of Behavioral Nutrition and Physical Activity
|
November 22, 2025
Digital assessment of real-world walking in people with impaired mobility: How many hours and days are needed?
Joren Buekers, Julia Chernova, Sarah Koch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 22, 2021
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
Carl M Thielmann, Johanna Matull, Anne Zaremba, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 11, 2023
Characterisation and outcome of RAC1 mutated melanoma
Georg C Lodde, Philipp Jansen, Rudolf Herbst, et al.
Annals of the American Thoracic Society
|
September 23, 2024
Validation of the Late-Life Function and Disability Instrument in People Living with COPD
Astrid Blondeel, Heleen Demeyer, Victoria Alcaraz-Serrano, et al.
The European Respiratory Journal
|
May 22, 2025
How do people with COPD walk? A European study on digitally measured real-world gait
Laura Delgado-Ortiz, Joren Buekers, Nikolaos Chynkiamis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2021
NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors
Carl M Thielmann, Eleftheria Chorti, Johanna Matull, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 108) with videos related to
Sort By:
Page
of 11
Scientific Reports
|
March 21, 2026
Construct validity of real-world digital mobility outcomes in patients after proximal femoral fracture: a cross-sectional observational study
Tobias Eckert, Martin Aursand Berge, Michael Long, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 17, 2019
Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks
Roman C Maron, Michael Weichenthal, Jochen S Utikal, et al.
Trials
|
January 17, 2026
Recruitment of the multiple sclerosis cohort within the European Mobilise-D clinical validation study-lessons learnt, baseline demographics and clinical characteristics
Gavin Brittain, Ellen Buckley, Vita Lanfranchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 17, 2024
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomas
Philipp Jansen, Wolfgang Galetzka, Georg C Lodde, et al.
The International Journal of Behavioral Nutrition and Physical Activity
|
November 22, 2025
Digital assessment of real-world walking in people with impaired mobility: How many hours and days are needed?
Joren Buekers, Julia Chernova, Sarah Koch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 22, 2021
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
Carl M Thielmann, Johanna Matull, Anne Zaremba, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 11, 2023
Characterisation and outcome of RAC1 mutated melanoma
Georg C Lodde, Philipp Jansen, Rudolf Herbst, et al.
Annals of the American Thoracic Society
|
September 23, 2024
Validation of the Late-Life Function and Disability Instrument in People Living with COPD
Astrid Blondeel, Heleen Demeyer, Victoria Alcaraz-Serrano, et al.
The European Respiratory Journal
|
May 22, 2025
How do people with COPD walk? A European study on digitally measured real-world gait
Laura Delgado-Ortiz, Joren Buekers, Nikolaos Chynkiamis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2021
NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors
Carl M Thielmann, Eleftheria Chorti, Johanna Matull, et al.
Page
of 11